BRIDGEWATER, NJ--(Marketwire - Mar 27, 2012) - Elsevier Business Intelligence (EBI) (NASDAQ: ENL) is proud to host the 19th Annual Euro-Biotech Partnering Summit at the elegant Hilton Arc de Triomphe in Paris this spring, from May 30 to June 1. Top executives from around the globe are invited to join two remarkable keynote speakers from GlaxoSmithKline, Paul Bolno, VP, Business Development, Asia and Ian Tomlinson, SVP, Worldwide Business Development and Biopharm R&D as well as the premier biopharma dealmakers in the industry to discuss and debate new ways of sourcing, developing and marketing innovation.
Expected to sell-out, this global forum promises to combine carefully selected company presentations, extensive networking opportunities with one-on-one partnering, and dynamic content discussions that will encourage attendees to draw on global examples of innovation to find new products and maximize efficiency.
Over the three day period, some of the most renowned speakers in industry will offer their first-hand perspectives on M&A, dealmaking trends, alliance structures, deal terms, European marketing rights, bio-tech financing, and much more. Such speakers include but are not limited to: Christoph Pittius, PhD, VP of Partnering & Business Development for AstraZeneca; Robert Bagdorf, VP of Worldwide Business Development for Pfizer, Inc.; Klaus Wilgenbus, Corporate SVP of PM Business Development and Licensing/Strategy for Boehringer Ingelheim; and Lawson Macartney, PhD, SVP of Emerging Business Unit for Research and Development of Specialty Pharma for Shire.
The agenda is action-packed with topics that are focused on those important trends that are changing how companies do business including:
- Revolutionizing R&D
- Preparing to Outlicense: How to be Market Ready
- Reaching the Customer: New Channels for Selling Pharmaceuticals
- Asia: Preparing for Global Leadership
- Creative R&D: New Sources for Innovation
- Reinventing Venture Capital: Sourcing New Funds, Risks, and Rewards
This year's summit will also be the only European Partnering Event to feature EBI's Strategic Transactions Database, one of the most effective research tools available, offering the most comprehensive deals and tech transfer data in the marketplace. Strategic Transactions can help executives negotiate with confidence by enabling them to value their products, create benchmarks and understand their competition's strategy.
In addition, attendees will also have access to the Euro-Biotech Proprietary Partnering software, which facilitates attendees in meeting one-on-one with other key decision-makers and networking with their peers for a more personal experience in an intimate setting. It is also linked to Strategic Transactions and the IN VIVO articles database for quick access to partner data and industry information.
Executives are strongly encouraged to join EBI this spring and take full advantage of this opportunity -- all in one of the world's most captivating cities! Attendees will be able to discover the right partners from over twenty-five promising presenting companies, meet hundreds of C-level and senior-level business development attendees at networking events, one-on-one meetings and cocktail receptions, and hone their dealmaking skills at powerful plenary panel discussions.
For registration information about this sell-out conference, or to hear what past attendees are saying about The Euro-Biotech Partnering Summit, visit www.eurobiotechsummit.com.
About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI) is global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, NJ; Norwalk, CT; Rockville, MD; and Irvine, CA.